Pravigard PAC, the first statin and aspirin combo

Bristol-Myers Squibb is now marketing Pravigard PAC, the first statin and aspirin combo.

It's approved to prevent MIs, strokes, and death in patients who already have cardiovascular disease.

But it can also be used in other patients who are candidates for both pravastatin and aspirin.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote